What we do

Our fundamental aim is offering to woman and men all over the world a better quality of life.

We give physicians effective tools supporting their clinical practice.

Our products boast a preview experience on the Italian market and proved efficacy in several clinical studies.

To make these products available worldwide we establish trade relationships of out-licensing with all the Companies, little, medium and big ones, that believe in our mission and would like to be part of this innovative process.

Our company has the aim to ensure the success of every Partner, that’s why we offer them all our know-how, instruments and support. They have to only let be driven along the way.

We surely want to add value to the Group, spreading Lo.Li.Pharma brand and purpose.

This our commitment has been the guide of the Company in the past and it will be forever.

Focus Areas



Breast Care





Myo-inositol & Male infertility

Myo-inositol & Male infertility

Introduction Why myo-inositol is crucial for male reproductive system/reproduction/fertility? It could look like a little strange that a molecule could be so important for the correct functioning of male reproductive system, but it starts making sense if we think...


Our portfolio has been enriched with a new product: Eudiamet 40:1. Wrong habits and bad nutrition affect our health more then we can imagine. The current data show that people all over the world are increasingly weak and at high risk to develop diseases. The...



The last 20 years were characterized by a progressive enhancing of the average body weight of the population of the high-income countries. This trend is the result of faster availability of food, due to the economic growth, the growing availability of abundant, the...

The new European Privacy Regulation

The new European Privacy Regulation

The term "privacy" is now part of common use and can be identified, in the Italian legal system, as the individual's right to privacy for any type of intrusion or disclosure by third parties, in the absence of authorization. The new legislation already in force is...